Imatinib Recruiting Phase 3 Trials for Sarcomas Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02413736Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST